Current status of clinical application for radiofrequency ablation / 介入放射学杂志

Radiofrequency ablation(RFA)is a new, safe, effective and minimally invasive treatment for solid tissue tumors extensively special for treating primary and metastatic hepatic cancer, particularly the small ones. Recent advances in the device technology and combination with other methods promotes RFA a realistic treatment option for larger tumors and furthermore RFA recently has been recommended for the treatment of neoplasms of bone, kidney, adrenal gland, lung, breast and thyroid gland, etc. This article comprehends the mechanism of RFA and current status of clinical application with evaluation of the clinical efficacy.